Last week, readers were most interested in a story about FDA approving Cleveland Diagnostics' prostate cancer test.

The test, which will use Iso-PAS technology, will be developed by Nipro of Japan in collaboration with other companies, institutes, and nonprofit organizations.

The medical center will use PathAI's AISight Dx image management system to evaluate algorithms for a variety of applications.